Huahai Pharmaceutical (600521.SH): “Huahai debt conversion” is expected to trigger a downward correction in the conversion price
Gelonghui Finance · 03/03 17:45
Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.